Rapid Micro Biosystems Stock Revenue
| RPID Stock | USD 3.42 0.07 2.01% |
Fundamental analysis of Rapid Micro allows traders to better anticipate movements in Rapid Micro's stock price by examining its financial health and performance throughout various phases of its business cycle.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Rapid Micro Biosystems Company Revenue Analysis
Rapid Micro's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Rapid Micro Revenue | 28.05 M |
Most of Rapid Micro's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Rapid Micro Biosystems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, Rapid Micro Biosystems reported 28.05 M of revenue. This is 99.63% lower than that of the Wireless Telecommunication Services sector and 98.9% lower than that of the Communication Services industry. The revenue for all United States stocks is 99.7% higher than that of the company.
Rapid Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Rapid Micro's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Rapid Micro could also be used in its relative valuation, which is a method of valuing Rapid Micro by comparing valuation metrics of similar companies.Rapid Micro is currently under evaluation in revenue category among its peers.
Rapid Fundamentals
| Return On Equity | -0.52 | ||||
| Return On Asset | -0.28 | ||||
| Profit Margin | (1.51) % | ||||
| Operating Margin | (1.62) % | ||||
| Current Valuation | 117.18 M | ||||
| Shares Outstanding | 39.33 M | ||||
| Shares Owned By Insiders | 10.83 % | ||||
| Shares Owned By Institutions | 60.32 % | ||||
| Number Of Shares Shorted | 409.49 K | ||||
| Price To Book | 2.23 X | ||||
| Price To Sales | 5.16 X | ||||
| Revenue | 28.05 M | ||||
| Gross Profit | 1.82 M | ||||
| EBITDA | (46.56 M) | ||||
| Net Income | (46.89 M) | ||||
| Cash And Equivalents | 145.1 M | ||||
| Cash Per Share | 3.46 X | ||||
| Total Debt | 6.17 M | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 13.45 X | ||||
| Book Value Per Share | 1.50 X | ||||
| Cash Flow From Operations | (44.15 M) | ||||
| Short Ratio | 5.24 X | ||||
| Earnings Per Share | (1.08) X | ||||
| Target Price | 8.0 | ||||
| Number Of Employees | 163 | ||||
| Beta | 1.33 | ||||
| Market Capitalization | 152.97 M | ||||
| Total Asset | 98.17 M | ||||
| Retained Earnings | (475.27 M) | ||||
| Working Capital | 63.35 M | ||||
| Current Asset | 217 K | ||||
| Current Liabilities | 6.84 M | ||||
| Net Asset | 98.17 M |
About Rapid Micro Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Rapid Micro Biosystems's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rapid Micro using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rapid Micro Biosystems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Rapid Micro Biosystems is a strong investment it is important to analyze Rapid Micro's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Rapid Micro's future performance. For an informed investment choice regarding Rapid Stock, refer to the following important reports:Check out Rapid Micro Piotroski F Score and Rapid Micro Altman Z Score analysis. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Measuring and Control Equipment space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rapid Micro. If investors know Rapid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rapid Micro listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Rapid Micro Biosystems is measured differently than its book value, which is the value of Rapid that is recorded on the company's balance sheet. Investors also form their own opinion of Rapid Micro's value that differs from its market value or its book value, called intrinsic value, which is Rapid Micro's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rapid Micro's market value can be influenced by many factors that don't directly affect Rapid Micro's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rapid Micro's value and its price as these two are different measures arrived at by different means. Investors typically determine if Rapid Micro is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rapid Micro's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.